Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_provenance.
- NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_assertion description "[Activation of PPARgamma, a nuclear hormone receptor important for lipid and glucose homeostasis, may present a new therapeutic approach for breast cancer, since PPARgamma agonists promote cell cycle arrest, differentiation and apoptosis in breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_provenance.
- NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_assertion evidence source_evidence_literature NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_provenance.
- NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_assertion SIO_000772 18288403 NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_provenance.
- NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_assertion wasDerivedFrom befree-2016 NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_provenance.
- NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_assertion wasGeneratedBy ECO_0000203 NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_provenance.
- befree-2016 importedOn "2016-02-19" NP656555.RA-R5Jjc0dHShI_yH7-AXl0biKcdwJLm0DkOybw5XV1Bk130_provenance.